Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Aclaris Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 96 | 1 | 103 | +8 |
| Shares | 91.9M | 11.2K | 85.7M | −6.18M (−6.7%) |
| Value | $130.4M | $15.9K | $162.8M | +$32.4M (+24.8%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ameriprise Financial Inc | 1,277,817 | $2.43M | 0.00% |
| Three Bridge Wealth Advisors, LLC | 714,823 | $1.36M | 0.35% |
| ADAR1 Capital Management, LLC | 373,682 | $710.0K | 0.07% |
| Jane Street Group, LLC | 73,113 | $138.9K | 0.00% |
| Panagora Asset Management Inc | 45,585 | $86.6K | 0.00% |
| Oxford Asset Management LLP | 36,351 | $69.1K | 0.02% |
| AQR Capital Management LLC | 34,952 | $66.4K | 0.00% |
| American Century Companies Inc | 31,788 | $60.4K | 0.00% |
| Axq Capital, LP | 13,969 | $26.5K | 0.01% |
| Two Sigma Securities, LLC | 10,586 | $20.1K | 0.00% |
| Tower Research Capital LLC (TRC) | 6,500 | $12.3K | 0.00% |
| The PNC Financial Services Group, Inc. | 2,039 | $3.87K | 0.00% |
| CWM, LLC | 275 | $1.00K | 0.00% |
| SRS Capital Advisors, Inc. | 447 | $849 | 0.00% |
| Clearstead Advisors, LLC | 1 | $2 | 0.00% |
Sold out (7)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Cantor Fitzgerald, L. P. | 451,120 | $640.6K |
| Squarepoint Ops LLC | 390,583 | $554.6K |
| Gsa Capital Partners LLP | 46,969 | $67.0K |
| Marex Group plc | 14,400 | $20.4K |
| Caitong International Asset Management Co., Ltd | 1,292 | $1.83K |
| Federated Hermes, Inc. | 902 | $1.28K |
| Simplex Trading, LLC | 1,336 | $1.00K |
Not filed for Q3 2025 yet (1)
Institutions that held Aclaris Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| CIBC World Markets Corp | 11,184 | $15.9K |